NYSE:EVH - Evolent Health Stock Price, News & Analysis

$7.84
-0.04 (-0.51 %)
(As of 09/20/2019 05:50 AM ET)
Today's Range
$7.78
Now: $7.84
$8.05
50-Day Range
$5.83
MA: $7.04
$7.93
52-Week Range
$5.50
Now: $7.84
$29.05
Volume1.12 million shs
Average Volume1.10 million shs
Market Capitalization$662.64 million
P/E RatioN/A
Dividend YieldN/A
Beta1.06
Evolent Health, Inc, through its subsidiary, Evolent Health LLC, provides health care delivery and payment solutions in the United States. The company operates as a managed services firm that supports health systems and physician organizations in migration toward value-based care and population health management. Its services include providing customers with a population management platform, integrated data and analytics capabilities, pharmacy benefit management services, and comprehensive health plan administration services. Read More…

Industry, Sector and Symbol

Industry Management services
Sub-IndustryN/A
SectorComputer and Technology
CUSIPN/A
Phone571-389-6000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$627.06 million
Cash Flow$0.2765 per share
Book Value$14.44 per share

Profitability

Net Income$-52,660,000.00

Miscellaneous

Employees3,800
Market Cap$662.64 million
Next Earnings Date11/5/2019 (Estimated)
OptionableOptionable

Receive EVH News and Ratings via Email

Sign-up to receive the latest news and ratings for EVH and its competitors with MarketBeat's FREE daily newsletter.


Evolent Health (NYSE:EVH) Frequently Asked Questions

What is Evolent Health's stock symbol?

Evolent Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "EVH."

How were Evolent Health's earnings last quarter?

Evolent Health Inc (NYSE:EVH) issued its quarterly earnings data on Tuesday, August, 6th. The technology company reported ($0.26) earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of ($0.29) by $0.03. The technology company earned $192 million during the quarter, compared to the consensus estimate of $192.51 million. Evolent Health had a negative net margin of 14.67% and a negative return on equity of 6.47%. Evolent Health's revenue for the quarter was up 33.1% on a year-over-year basis. During the same quarter last year, the company earned ($0.03) earnings per share. View Evolent Health's Earnings History.

When is Evolent Health's next earnings date?

Evolent Health is scheduled to release their next quarterly earnings announcement on Tuesday, November 5th 2019. View Earnings Estimates for Evolent Health.

What price target have analysts set for EVH?

8 brokers have issued 1 year price objectives for Evolent Health's shares. Their predictions range from $10.00 to $35.00. On average, they expect Evolent Health's stock price to reach $20.9375 in the next year. This suggests a possible upside of 167.1% from the stock's current price. View Analyst Price Targets for Evolent Health.

What is the consensus analysts' recommendation for Evolent Health?

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Evolent Health in the last year. There are currently 8 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Evolent Health.

Has Evolent Health been receiving favorable news coverage?

Headlines about EVH stock have trended negative this week, InfoTrie Sentiment Analysis reports. The research group scores the sentiment of press coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Evolent Health earned a media sentiment score of -2.9 on InfoTrie's scale. They also assigned media coverage about the technology company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an effect on the company's share price in the next few days. View News Stories for Evolent Health.

Who are some of Evolent Health's key competitors?

Some companies that are related to Evolent Health include R1 RCM (RCM), Franklin Covey (FC), Jupai (JP), PHI Group (PHIL) and Rainmaker Systems (VCTL).

What other stocks do shareholders of Evolent Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Evolent Health investors own include CA (CA), BlackRock (BLK), Universal Insurance (UVE), Endologix (ELGX), Chipotle Mexican Grill (CMG), Advanced Micro Devices (AMD), Aegean Marine Petroleum Network (ANW), Micron Technology (MU), Mobileye (MBBYF) and NVIDIA (NVDA).

Who are Evolent Health's key executives?

Evolent Health's management team includes the folowing people:
  • Mr. Frank J. Williams, Co-Founder, CEO & Chairman (Age 52)
  • Mr. Seth Blackley, Co-Founder, Pres & Director (Age 40)
  • Mr. Thomas Peterson III, Co-Founder & COO (Age 49)
  • Mr. Nicholas McGrane, Chief Financial Officer (Age 51)
  • Ms. Lydia Stone, VP, Chief Accounting Officer & Controller (Age 43)

When did Evolent Health IPO?

(EVH) raised $150 million in an IPO on Friday, June 5th 2015. The company issued 10,000,000 shares at $14.00-$16.00 per share. J.P. Morgan and Goldman Sachs served as the underwriters for the IPO and Wells Fargo Securities, William Blair, SunTrust Robinson Humphrey and Leerink Partners were co-managers.

Who are Evolent Health's major shareholders?

Evolent Health's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (7.95%), BlackRock Inc. (6.00%), Riverbridge Partners LLC (4.12%), Eagle Asset Management Inc. (2.24%), Cortina Asset Management LLC (2.03%) and Marshall Wace LLP (1.95%). Company insiders that own Evolent Health stock include Cheryl Scott, Doug S Aron, Frank J Williams, Jonathan Weinberg, Kenneth A Samet, Lydia Stone, Michael D'amato, Seth Blackley, Thomas Peterson III and Unitedhealth Group Inc. View Institutional Ownership Trends for Evolent Health.

Which institutional investors are selling Evolent Health stock?

EVH stock was sold by a variety of institutional investors in the last quarter, including Bank of New York Mellon Corp, Waddell & Reed Financial Inc., D. E. Shaw & Co. Inc., Eagle Asset Management Inc., Invesco Ltd., Riverbridge Partners LLC, First Trust Advisors LP and Cubist Systematic Strategies LLC. View Insider Buying and Selling for Evolent Health.

Which institutional investors are buying Evolent Health stock?

EVH stock was purchased by a variety of institutional investors in the last quarter, including Marshall Wace LLP, Vanguard Group Inc., Canada Pension Plan Investment Board, Prudential Financial Inc., Voce Capital Management LLC, Nuveen Asset Management LLC, Marshall Wace North America L.P. and Handelsbanken Fonder AB. Company insiders that have bought Evolent Health stock in the last two years include Doug S Aron, Kenneth A Samet and Michael D'amato. View Insider Buying and Selling for Evolent Health.

How do I buy shares of Evolent Health?

Shares of EVH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Evolent Health's stock price today?

One share of EVH stock can currently be purchased for approximately $7.84.

How big of a company is Evolent Health?

Evolent Health has a market capitalization of $662.64 million and generates $627.06 million in revenue each year. The technology company earns $-52,660,000.00 in net income (profit) each year or ($0.35) on an earnings per share basis. Evolent Health employs 3,800 workers across the globe.View Additional Information About Evolent Health.

What is Evolent Health's official website?

The official website for Evolent Health is http://www.evolenthealth.com/.

How can I contact Evolent Health?

Evolent Health's mailing address is 800 NORTH GLEBE RD SUITE 500, ARLINGTON VA, 22203. The technology company can be reached via phone at 571-389-6000.


MarketBeat Community Rating for Evolent Health (NYSE EVH)

Community Ranking:  3.2 out of 5 (star star star)
Outperform Votes:  427 (Vote Outperform)
Underperform Votes:  246 (Vote Underperform)
Total Votes:  673
MarketBeat's community ratings are surveys of what our community members think about Evolent Health and other stocks. Vote "Outperform" if you believe EVH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe EVH will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 9/20/2019 by MarketBeat.com Staff

Featured Article: Forex

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel